📧 Communication
Report DistributionCommunication Details
From
Cowen
Linked to Cowen
To
Michael Cella
Michael Cella
Date
February 25, 2019
Subject
Cowen Collaborative Insights
Message Content
Research report regarding GW Pharma and Epidiolex efficacy/safety data.
📄 Source Document
HOUSE_OVERSIGHT_024904.jpg
ESTATE Collection
Document Summary
A page from a Cowen research report dated February 25, 2019, analyzing the efficacy and safety of the drug Epidiolex by GW Pharma. It includes charts and tables detailing seizure reduction rates and adverse events in patients with Dravet Syndrome and Lennox-Gastaut Syndrome. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was part of a document production to the US House Oversight Committee.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein communication